At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 274 enrolled
Drug / intervention
Control +1 moredrug
Likely dose
Control 2 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Comparison of Orthovisc® to Corticosteroid Injection in Shoulder Osteoarthritis: Orthovisc Randomized Clinical Trial
In Brief
A Phase 3 clinical trial evaluating Orthovisc and Control for Glenohumeral Osteoarthritis. Completed, enrolled 274 participants across 13 sites.
Detailed Summary
A comparison of Orthovisc to corticosteroid injections in the shoulder for pain due to osteoarthritis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlenohumeral Osteoarthritis
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2006
First PostedFeb 2007
Primary CompletionFeb 2010
Study CompletionAug 2011
TodayJul 2026
First PostedFeb 19, 2007
Enrollment StartDec 1, 2006
Primary CompletionFeb 1, 2010
Study CompletionAug 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 19.4 years ago
Interventions
Orthoviscdevice
Orthovisc injection
Controldrug
Celestone (betamethasone sodium phosphate and acetate) - 2 mL